Cardioxyl Pharmaceuticals' Series B Round

Cardioxyl Pharmaceuticals raised a round of funding on August 11, 2009.

Cardioxyl Pharmaceuticals is a privately held, clinical stage biopharmaceutical company developing therapies for the treatment of cardiovascular disease, focusing on the discovery, development and com…

Articles about Cardioxyl Pharmaceuticals' Series B Round: